• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Research
  1. Teva's generic version of AstraZeneca's Nexium gets FDA approval

    Teva's generic version of AstraZeneca's Nexium gets FDA approval

  2. Supreme Court Sides With Teva in Patent Case on Copaxone

    Supreme Court Sides With Teva in Patent Case on Copaxone

  3. FDA Rejects Antares' Application for Generic Migraine Drug

    FDA Rejects Antares' Application for Generic Migraine Drug

  4. Teva Launches Generic Diovan® in the United States

    Teva Launches Generic DiovanĀ® in the United States

  5. ADR Shares End Mixed; SAP Shares Fall

    ADR Shares End Mixed; SAP Shares Fall

  6. Research and Markets: Lung Cancer Clinical Trial Overview 2014

    Research and Markets: Lung Cancer Clinical Trial Overview 2014

  7. CTI BioPharma Announces 2015 Outlook and Recent Drug Portfolio Progress

    CTI BioPharma Announces 2015 Outlook and Recent Drug Portfolio Progress

  8. Yissum and PhytoTech Medical to Collaborate on Novel Delivery System for Medical Cannabis

    Yissum and PhytoTech Medical to Collaborate on Novel Delivery System for Medical Cannabis

  9. Research and Markets: Hypertension - Pipeline Review, H2 2014

    Research and Markets: Hypertension - Pipeline Review, H2 2014

  10. Deckers Brands Appoints David Lafitte To Chief Operating Officer

    Deckers Brands Appoints David Lafitte To Chief Operating Officer

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.